+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

From
From
From
Pseudomonas Aeruginosa Infection Treatment Market - Product Thumbnail Image

Pseudomonas Aeruginosa Infection Treatment Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Coxsackievirus Infections Treatment Global Market Report 2025 - Product Thumbnail Image

Coxsackievirus Infections Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
HSV-1 Keratitis - Competitive landscape, 2024 - Product Thumbnail Image

HSV-1 Keratitis - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more